Select Committee on European Legislation Ninth Report


TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES: RESEARCH

6.   We consider that the following raises questions of political importance, but make no recommendation for its further consideration at this stage:--

Department of Trade and Industry

(17684)
11759/96
COM(96)582
Commission Communication on a European initiative on transmissible spongiform encephalopathies (TSE).
Legal base: --

      The document

        6.1  This document is put forward in response to an invitation from the 7 October Research Council to the Commission to present a Communication to the 5 December Council on stepping up research on transmissible spongiform encephalopathies (TSE). In June the Commission had publicised its intention to propose an action plan for which supplementary funding would be needed.

        6.2  This Communication includes an action plan which draws on the recommendations of the report of a group chaired by a Professor Weissmann, appointed by the Commission in April 1996 to draw up an inventory of the state of knowledge and to propose research priorities. It also takes into account recommendations from the Multidisciplinary Scientific Committee. The Financial Statement is not yet available in English.

        6.3  The five priority areas are:

          --  clinical and epidemiological research on human spongiform encephalopathies (SE);

          --  the infectious agent and its transmission mechanisms;

          --  diagnosis;

          --  evaluation of risk; and

          --  treatment and prevention.

        6.4  Within these areas, 24 research topics have been identified. Given the complexity of the subject, several research projects per topic are often required, according to the Commission. It takes the view that co-ordination of the Member States, research activities on TSE should be strengthened, and explains that it has proposed a relatively high figure, 5 million ECU (£3.75 million)[11], as the requirement is for more than "the lightweight co-ordination which is usually practised in research matters" and "the creation of databases and training programmes are both essential and, inevitably, costly".

        6.5  In the Communication, the Commission informs the Council that it is preparing a second revised proposal on the financial supplement to the Fourth Framework Programme.

        The Government's view

        6.6  In his Explanatory Memorandum (dated 17 December) the Parliamentary Under-Secretary of State for Science and Technology, Department of Trade and Industry (Mr Ian Taylor) says that the Commission plan is generally thorough, well thought out and in accordance with UK priorities. He comments that:

          "The UK has a substantial and relatively long-standing research programme into TSEs, and it is important that the Commission take account of national research efforts, and the scope for improving co-ordination between Member States' TSE activities."

        6.7  Two important safeguards secured by the UK include the participation of experts from outside the EU in the peer review process which is used to allocate funding and provision for a review at the end of 1997.

        6.8  The Minister tells us that the Communication was approved by Council on 5 December. He also refers to approval having been given to the proposal for 100 million ECU of additional funding for the Fourth Framework Programme, from which 35 million ECU will be designated for TSE research and vaccines. This is a reference to the proposal dealt with in paragraph 5 of this Report.

        Conclusion

        6.9  The question of funding is relevant to this proposal as it is to the revision of the Fourth Framework Programme. We are therefore not clearing this document until we have seen the further information requested on the financial perspective.


11.£1 = 1.3322 ECU. Back

 


© Parliamentary copyright 1997
Prepared 28th January 1997